The DOI matches its Crossref record.
SIC, a Secreted Protein of Streptococcus pyogenesThat Inactivates Antibacterial Peptides
Open accessAbstract
Some isolates of the significant human pathogen Streptococcus pyogenes, including virulent strains of the M1 serotype, secrete protein SIC. This molecule, secreted in large quantities, interferes with complement function. As a result of natural selection, SIC shows a high degree of variation. Here we provide a plausible explanation for this variation and the fact that strains of the M1 serotype are the most frequent cause of severe invasive S. pyogenes infections. Thus, protein SIC was found to inactivate human neutrophil alpha-defensin and LL-37, two major antibacterial peptides involved in bacterial clearance. This inactivation protected S. pyogenes against the antibacterial effect of the peptides. Moreover, SIC isolated from S. pyogenes of the M1 serotype was more powerful in this respect than SIC variants from strains of M serotypes 12 and 55, serotypes rarely connected with invasive infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The co-evolution of host cationic antimicrobial peptides and microbial resistance
Peschel, A., & Sahl, H.-G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1441 · Cited by 1,062
LL-37, the only human member of the cathelicidin family of antimicrobial peptides
Dürr, U. H. N., Sudheendra, U. S., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.030 · Cited by 1,049
Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00101-13 · Cited by 908
Guilhelmelli, F., Vilela, N., Albuquerque, P., Derengowski, L. D. S., Silva-Pereira, I., & Kyaw, C. M. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00353 · Cited by 546
Molecular insight into invasive group A streptococcal disease
Cole, J. N., Barnett, T. C., Nizet, V., & Walker, M. J. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2648 · Cited by 377
Bacterial strategies of resistance to antimicrobial peptides
Joo, H.-S., Fu, C.-I., & Otto, M. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0292 · Cited by 360
Capsule polysaccharide is a bacterial decoy for antimicrobial peptides
Llobet, E., Tomás, J. M., & Bengoechea, J. A. (2008) · Microbiology · doi:10.1099/mic.0.2008/022301-0 · Cited by 312
The pathogenesis of streptococcal infections: from Tooth decay to meningitis
Mitchell, T. J. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro771 · Cited by 307
Papo, N., & Shai, Y. (2003) · Peptides · doi:10.1016/j.peptides.2003.09.013 · Cited by 298
Antimicrobial Peptide Resistance Mechanisms of Human Bacterial Pathogens
(2006) · Current Issues in Molecular Biology · doi:10.21775/cimb.008.011 · Cited by 289
Kristian, S. A., Datta, V., Weidenmaier, C., Kansal, R., Fedtke, I., Peschel, A., Gallo, R. L., & Nizet, V. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.19.6719-6725.2005 · Cited by 258
Responses of innate immune cells to group A Streptococcus.
Fieber, C., & Kovarik, P. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00140 · Cited by 56
“Streptococcal inhibitor of complement (SIC) inhibits complement-mediated formation of the membrane attack complex (MAC) and decreases antimicrobial peptide production by neutrophils (Akesson et al., 1996; Hoe et al., 2002; Frick et al., 2003).”
BackgroundSoderholm, A. T., Barnett, T. C., Sweet, M. J., & Walker, M. J. (2018) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr0617-227rr · Cited by 51
Metadata
- Authors
- Frick, I.-M., Åkesson, P., Rasmussen, M., Schmidtchen, A., & Björck, L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 278
- Issue
- 19
- Pages
- 16561-16566
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2126306331
- Cited by
- 193
- References
- 0
- FWCI
- 11.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.